VRNA
Verona Pharma
VRNA
VRNA
Delisted
VRNA was delisted on the 6th of October, 2025.
125 hedge funds and large institutions have $957M invested in Verona Pharma in 2024 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 43 increasing their positions, 33 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
0.68% more ownership
Funds ownership: 10.34% → 11.02% (+0.68%)
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
12% less capital invested
Capital invested by funds: $1.08B → $957M (-$128M)
Holders
125
Holding in Top 10
7
Calls
$10.8M
Puts
$10.5M
Top Buyers
| 1 | +$19M | |
| 2 | +$19M | |
| 3 | +$13.7M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$11.7M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$11.2M |
Top Sellers
| 1 | -$33.8M | |
| 2 | -$24M | |
| 3 | -$19.2M | |
| 4 |
FTM
First Turn Management
Del Mar,
California
|
-$15.7M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$14.6M |